Precision neurodiagnostics

Precision neurodiagnostics

Neso is developing a new generation of diagnostic tools to improve how neurocognitive disorders are detected, diagnosed and monitored. Earlier, more objectively and at scale.

The problem

Accelerating the diagnosis of cognitive impairment

Millions of people live with undiagnosed or late-diagnosed neurocognitive conditions. Today’s assessments rely largely on questionnaires and paper-based tests that depend on the clinician, the setting and the patient’s education and language. Long waiting times and new disease-modifying therapies have made early and accurate diagnosis more consequential than ever.

People living with dementia worldwide
57M
78M
139M
Today2021 estimate
2030projected
2050projected
Source: World Health Organization
Our approach

A targeted, objective measure of brain function

Neso combines neuroscience, targeted acoustic stimulation and artificial intelligence to measure brain function directly. Our platform uses a non-invasive approach to capture how the brain responds, and translates that signal into clear, decision-grade information for clinicians.

01 /

Objective

A direct measure of brain function, independent of self-report, education or language.

02 /

Fast and scalable

Minutes to administer by trained healthcare staff. Built for routine care, not just specialist centres.

03 /

Decision-ready

Designed to support clinical judgement at the points where diagnosis and monitoring decisions are made.

Partnerships/Collaborators

Innovate UK
King's College London
University of Surrey
NHS Surrey and Borders Partnership
King's 20
CPI